Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases is a research paper published in Pathogens (2022). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: AI153202
National Institutes of Health
Grant: P20GM130448
National Institutes of Health
Grant: P20GM113117
National Institutes of Health
Grant: P20GM103638
National Institutes of Health
Grant: GM111385
NIAID NIH HHS
Grant: R56 AI153202
National Institutes of Health
Grant: 1P20GM130448-01A1
Center on Emerging and Zoonotic Infectious Diseases
National Institutes of Health
Grant: 2P20GM103638-06
Molecular Analysis of Disease Pathways
National Institutes of Health
Grant: 1R56AI153202-01
Developing Bacterial Glycosyltransferase Inhibitors as Anti-Virulence Drugs
National Institutes of Health
Grant: 5P20GM113117-03
Chemical Biology of Infectious Disease
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
Keywords
Sustainable Development Goals